Dimensional Fund Advisors LP Increases Stock Position in Masimo Co. (NASDAQ:MASI)

Dimensional Fund Advisors LP increased its stake in shares of Masimo Co. (NASDAQ:MASI - Free Report) by 8.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 647,720 shares of the medical equipment provider's stock after buying an additional 50,022 shares during the quarter. Dimensional Fund Advisors LP owned about 1.21% of Masimo worth $107,076,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in MASI. Jones Financial Companies Lllp purchased a new stake in shares of Masimo in the 4th quarter valued at $27,000. UMB Bank n.a. lifted its holdings in shares of Masimo by 180.9% in the 4th quarter. UMB Bank n.a. now owns 191 shares of the medical equipment provider's stock valued at $32,000 after buying an additional 123 shares during the period. Blue Trust Inc. grew its holdings in Masimo by 56.3% during the fourth quarter. Blue Trust Inc. now owns 197 shares of the medical equipment provider's stock worth $33,000 after acquiring an additional 71 shares during the period. Trust Co. of Vermont purchased a new stake in Masimo in the 4th quarter worth approximately $33,000. Finally, EverSource Wealth Advisors LLC lifted its stake in shares of Masimo by 40.0% in the 4th quarter. EverSource Wealth Advisors LLC now owns 224 shares of the medical equipment provider's stock valued at $37,000 after purchasing an additional 64 shares during the period. Hedge funds and other institutional investors own 85.96% of the company's stock.

Masimo Trading Down 1.3 %

Shares of NASDAQ MASI traded down $2.18 during trading on Wednesday, reaching $160.96. The stock had a trading volume of 347,440 shares, compared to its average volume of 660,960. The business's 50-day moving average price is $165.12 and its 200-day moving average price is $165.88. Masimo Co. has a fifty-two week low of $101.61 and a fifty-two week high of $194.88. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.11 and a current ratio of 2.01. The company has a market cap of $8.70 billion, a P/E ratio of 111.01 and a beta of 1.28.

Masimo (NASDAQ:MASI - Get Free Report) last issued its quarterly earnings results on Tuesday, February 25th. The medical equipment provider reported $1.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.42 by $0.38. The company had revenue of $600.70 million for the quarter, compared to analyst estimates of $593.35 million. Masimo had a net margin of 3.85% and a return on equity of 14.98%. On average, equities research analysts predict that Masimo Co. will post 4.1 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on MASI shares. Needham & Company LLC restated a "hold" rating on shares of Masimo in a research report on Thursday, April 10th. Wells Fargo & Company increased their price objective on Masimo from $193.00 to $205.00 and gave the stock an "overweight" rating in a research report on Wednesday, February 26th. Finally, Piper Sandler upped their target price on shares of Masimo from $210.00 to $215.00 and gave the company an "overweight" rating in a research report on Wednesday, February 26th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $194.80.

Insider Buying and Selling at Masimo

In other Masimo news, Director Craig B. Reynolds sold 2,053 shares of the firm's stock in a transaction on Friday, March 14th. The stock was sold at an average price of $166.13, for a total value of $341,064.89. Following the sale, the director now directly owns 16,581 shares in the company, valued at $2,754,601.53. This trade represents a 11.02 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Bilal Muhsin sold 30,000 shares of the company's stock in a transaction on Monday, March 10th. The shares were sold at an average price of $167.49, for a total transaction of $5,024,700.00. Following the completion of the transaction, the chief operating officer now owns 24,172 shares of the company's stock, valued at approximately $4,048,568.28. The trade was a 55.38 % decrease in their position. The disclosure for this sale can be found here. 9.70% of the stock is owned by corporate insiders.

Masimo Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.